IPN10200 Clinical Trials (2026): 6 Studies for Moderate to Severe Glabellar Lines & Cervical Dystonia
Hipa.ai Research · Source: ClinicalTrials.gov / AACT
Synced daily from ClinicalTrials.gov via AACT. Last sync: .
6 IPN10200 clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 5 indications (including Moderate to Severe Glabellar Lines & Cervical Dystonia) and 3,378 total planned enrollment. 2 Phase 3 IPN10200 trials and 2 Phase 2 are listed. 3 IPN10200 clinical trials are actively recruiting at 43 U.S. sites across 21 states. Most recent activity: NCT04752774 (Mar 2029).
Where to Participate: All IPN10200 Trial Sites in the U.S. (43 sites across 21 states)
Every actively recruiting IPN10200trial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.
| State | Facility | City | Trial | Map |
|---|---|---|---|---|
| CA | Rancho Los Amigos National Rehab | Downey90242 | NCT04752774 | Map |
| CA | Parkinson's & Mvmt Disorders Inst | Fountain Valley92708 | NCT06937931 | Map |
| CA | Clinical Testing of Beverly Hills | Los Angeles91436 | NCT07435428 | Map |
| CA | Eye Research Foundation | Newport Beach92663 | NCT07435428 | Map |
| CA | Steve Yoelin MD Medical Associates Inc | Newport Beach92663 | NCT07435428 | Map |
| CA | Skin and Beauty Center | Pasadena91105 | NCT07435428 | Map |
| CT | DMR Research, PLLC | Westport06880 | NCT07435428 | Map |
| FL | Skin and Cancer Associates (SCA) and the Center for Cosmetic Enhancement (CCE) - Aventura | Aventura33180 | NCT07435428 | Map |
| FL | Parkinson's Ds & Mvt Disorders Cntr | Boca Raton33486 | NCT06937931 | Map |
| FL | Weinkle Dermatology | Bradenton34209 | NCT07435428 | Map |
| FL | Miami Dermatology & Laser Research | Miami33133 | NCT07435428 | Map |
| GA | Emory Brain Health Center | Atlanta30329 | NCT06937931 | Map |
| GA | Kavali Plastic Surgery and Skin Renewal Center | Atlanta30328 | NCT07435428 | Map |
| IL | Chicago Cosmetic and Dermatologic Research | Chicago60654-5826 | NCT07435428 | Map |
| IL | DeNova Research | Chicago60610 | NCT07435428 | Map |
| IL | Rush Medical Center | Chicago60612 | NCT06937931 | Map |
| IN | LASSI - Laser and Skin Surgery Center of Indiana | Indianapolis46260 | NCT07435428 | Map |
| KS | Kansas Institute of Research | Overland Park66211 | NCT04752774 | Map |
| LA | DelRicht Research | New Orleans70115 | NCT07435428 | Map |
| LA | Etre, Cosmetic Dermatology and Laser Center | New Orleans70130 | NCT07435428 | Map |
| MD | Maryland Laser, Skin, & Vein Institute, LLC (MDLSV) | Hunt Valley21030 | NCT07435428 | Map |
| MD | Lawrence J. Green, MD. LLC | Rockville20850 | NCT07435428 | Map |
| MA | SkinCare Physicians | Chestnut Hill02467 | NCT07435428 | Map |
| MI | Michigan Center for Research Company | Clarkston48346 | NCT07435428 | Map |
| MI | Quest Research Institute | Farmington Hills48334 | NCT06937931 | Map |
| NE | Skin Specialists PC dba Schlessinger MD | Omaha68144 | NCT07435428 | Map |
| NH | StracSkin | Portsmouth03801 | NCT07435428 | Map |
| NY | Rejuva Center at Williams | Latham12110 | NCT07435428 | Map |
| NY | The Center for Dermatology, Cosmetic & Laser Surgery | Mount Kisco10549 | NCT07435428 | Map |
| NY | Dr. Z. Paul Lorenc MD, Office Of | New York10028 | NCT07435428 | Map |
| NY | Ichan Sch of Medicine @ Mt. Sinai | New York10029 | NCT06937931 | Map |
| NY | Luxurgery | New York10021 | NCT07435428 | Map |
| NY | Skin Search Of Rochester, Inc. | Rochester14623 | NCT07435428 | Map |
| NC | Aesthetic Solutions P.A. | Chapel Hill27517 | NCT07435428 | Map |
| NC | Dermatology, Laser & Vein Specialists of the Carolinas (DLVSC) - Charlotte Office | Charlotte28207 | NCT07435428 | Map |
| OH | Nash Research Group, LLC | Powell43065 | NCT07435428 | Map |
| OR | Oregon Dermatology and Research Center | Portland97210 | NCT07435428 | Map |
| PA | Einstein Physical Medicine and Rehabilitation at Elkins Park | Elkins Park19027 | NCT04752774 | Map |
| PA | Paddington Testing Company | Philadelphia19103 | NCT07435428 | Map |
| TN | Brian S. Biesman MD, PLLC | Nashville37203 | NCT07435428 | Map |
| TN | Tennessee Clinical Research Center | Nashville37215 | NCT07435428 | Map |
| TX | The University of Texas Southwestern Medical Center | Dallas75390 | NCT04752774 | Map |
| WA | Kingfisher Cooperative | Spokane99201 | NCT06937931 | Map |
IPN10200 clinical trials at a glance: phase × recruitment status
| Phase | recruiting | active not recruiting | Total |
|---|---|---|---|
| P1/P2 | 1 | 1 | 2 |
| P2 | 1 | 1 | 2 |
| P3 | 1 | 1 | 2 |
Recruiting IPN10200 clinical trials (3)
Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).
| NCT ID | Title | Phase | Indication | Enrollment | Started |
|---|---|---|---|---|---|
| NCT04752774 | LANTIMAA Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Upper Limb Spasticity. | P1/P2 | Spasticity | 240 | Apr 2021 |
| NCT07435428 | LAURITE 2A Study to Assess the Effectiveness and Safety of IPN10200 Over Time in Adults With Moderate to Severe Wrinkle-like Lines Between the Eyebrows | P3 | Moderate to Severe Glabellar Lines | 1,300 | Feb 2026 |
| NCT06937931 | CATALPAA Study of IPN10200 for the Treatment of Cervical Dystonia in Adults | P2 | Cervical Dystonia | 132 | Jun 2025 |
IPN10200 clinical trials by indication
Moderate to Severe Glabellar Lines (2)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT07435428 | LAURITE 2 | P3 | recruiting | A Study to Assess the Effectiveness and Safety of IPN10200 Over Time in Adults With Moderate to Severe Wrinkle-like Lines Between the Eyebrows |
| NCT07427797 | LAURITE 1 | P3 | active not recruiting | A Study to Assess the Effectiveness and Safety of IPN10200 in Adults With Moderate to Severe Wrinkle-like Lines Between the Eyebrows |
Cervical Dystonia (1)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT06937931 | CATALPA | P2 | recruiting | A Study of IPN10200 for the Treatment of Cervical Dystonia in Adults |
Episodic Migraine (1)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT06625060 | MERANTI | P2 | active not recruiting | A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults |
Spasticity (1)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT04752774 | LANTIMA | P1/P2 | recruiting | A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Upper Limb Spasticity. |
Moderate to Severe Upper Facial Lines (1)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT04821089 | LANTIC | P1/P2 | active not recruiting | A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Moderate to Severe Upper Facial Lines |
IPN10200 pivotal trial highlights (Phase 2/3/4)
Phase-2/3/4 studies with named acronyms — the registration-grade trials most cited in label discussions and Wikipedia.
| Acronym | NCT | Phase | Status | Indication | Enrollment | PubMed |
|---|---|---|---|---|---|---|
| LAURITE 2 | NCT07435428 | P3 | recruiting | Moderate to Severe Glabellar Lines | 1,300 | — |
| LAURITE 1 | NCT07427797 | P3 | active not recruiting | Moderate to Severe Glabellar Lines | 309 | — |
| CATALPA | NCT06937931 | P2 | recruiting | Cervical Dystonia | 132 | — |
| MERANTI | NCT06625060 | P2 | active not recruiting | Episodic Migraine | 670 | — |
All IPN10200 trials (6)
Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.
| NCT ID | Acronym | Title | Phase | Status | Enrollment | Sponsor | Started |
|---|---|---|---|---|---|---|---|
| NCT04752774 | LANTIMA | A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Upper Limb Spasticity. | P1/P2 | recruiting | 240 | Ipsen | Apr 2021 |
| NCT07435428 | LAURITE 2 | A Study to Assess the Effectiveness and Safety of IPN10200 Over Time in Adults With Moderate to Severe Wrinkle-like Lines Between the Eyebrows | P3 | recruiting | 1,300 | Ipsen | Feb 2026 |
| NCT06937931 | CATALPA | A Study of IPN10200 for the Treatment of Cervical Dystonia in Adults | P2 | recruiting | 132 | Ipsen | Jun 2025 |
| NCT06625060 | MERANTI | A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults | P2 | active not recruiting | 670 | Ipsen | Oct 2024 |
| NCT04821089 | LANTIC | A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Moderate to Severe Upper Facial Lines | P1/P2 | active not recruiting | 727 | Ipsen | Apr 2021 |
| NCT07427797 | LAURITE 1 | A Study to Assess the Effectiveness and Safety of IPN10200 in Adults With Moderate to Severe Wrinkle-like Lines Between the Eyebrows | P3 | active not recruiting | 309 | Ipsen | Feb 2026 |
IPN10200 clinical trials: frequently asked questions
- How many IPN10200 clinical trials are there?
- 6 IPN10200 clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 3 are actively recruiting participants.
- Are IPN10200 clinical trials recruiting in 2026?
- Yes — 3 IPN10200 trials are actively recruiting in 2026, with 43 U.S. sites across 21 states. See the recruiting trials and the per-state site list further down this page.
- What conditions is IPN10200 being studied for?
- IPN10200 is being studied for Moderate to Severe Glabellar Lines, Cervical Dystonia, Chronic Migraine, Episodic Migraine, Moderate to Severe Upper Facial Lines and 1 more. The trials are grouped by indication on this page.
- What phase is IPN10200 in?
- IPN10200 clinical trials span 2 Phase 3, 2 Phase 2. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.
- Who sponsors IPN10200 clinical trials?
- The lead sponsor across the most IPN10200 trials is Ipsen. Each trial row links to the full study detail page including sponsor information.
Sources and methodology
Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming IPN10200as an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.
Last refreshed .
Related pages on Hipa.ai: